Cameron Martino

Cameron Martino

Auto-generated profile, based on publicly available information

Cameron Martino

Department of Pediatrics, University of California San Diego, La Jolla, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Cell
Verified
Journal Article
Closed access
TCThomas Clausen
Thomas Clausen
DSDaniel R. Sandoval
Daniel R. Sandoval
CSCharlotte B. Spliid
Charlotte B. Spliid
JPJessica Pihl
Jessica Pihl
HPHailee R. Perrett
Hailee R. Perrett
JEJeffrey D. Esko
Jeffrey D. Esko

29 July 2022 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CMCameron Martino
Cameron Martino
ADAmanda Hazel Dilmore
Amanda Hazel Dilmore
ZBZachary M. Burcham
Zachary M. Burcham
JMJessica L. Metcalf
Jessica L. Metcalf
DJDilip Jeste
Dilip Jeste
RKRob Knight
Rob Knight

28 November 2022 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
JSJustin P. Shaffer
Justin P. Shaffer
LNLouis-Félix Nothias
Louis-Félix Nothias
LTLuke R. Thompson
Luke R. Thompson
JSJon G. Sanders
Jon G. Sanders
RSRodolfo A. Salido
Rodolfo A. Salido
SZShan Zhang
Shan Zhang
Despite advances in sequencing, lack of standardization makes comparisons across studies challenging and hampers insights into the structure and function of microbial communities across multiple habitats on a planetary scale. Here we present a multi-omics analysis of a diverse set of 880 microbial community samples collected for the Earth Microbiome Project. We include amplicon (16S, 18S, ITS) and shotgun metagenomic sequence data, and untargeted metabolomics data (liquid chromatography-tandem mass spectrometry and gas chromatography mass spectrometry). We used standardized protocols and analytical methods to characterize microbial communities, focusing on relationships and co-occurrences of microbially related metabolites and microbial taxa across environments, thus allowing us to explore diversity at extraordinary scale. In addition to a reference database for metagenomic and metabolomic data, we provide a framework for incorporating additional studies, enabling the expansion of existing knowledge in the form of an evolving community resource. We demonstrate the utility of this database by testing the hypothesis that every microbe and metabolite is everywhere but the environment selects. Our results show that metabolite diversity exhibits turnover and nestedness related to both microbial communities and the environment, whereas the relative abundances of microbially related metabolites vary and co-occur with specific microbial consortia in a habitat-specific manner. We additionally show the power of certain chemistry, in particular terpenoids, in distinguishing Earth’s environments (for example, terrestrial plant surfaces and soils, freshwater and marine animal stool), as well as that of certain microbes including Conexibacter woesei (terrestrial soils), Haloquadratum walsbyi (marine deposits) and Pantoea dispersa (terrestrial plant detritus). This Resource provides insight into the taxa and metabolites within microbial communities from diverse habitats across Earth, informing both microbial and chemical ecology, and provides a foundation and methods for multi-omics microbiome studies of hosts and the environment.

25 January 2023 in Nature
Verified
Journal Article
Open access
PDF file
MHMichal K. Handzlik
Michal K. Handzlik
JGJivani M. Gengatharan
Jivani M. Gengatharan
KFKatie E. Frizzi
Katie E. Frizzi
GMGrace H. McGregor
Grace H. McGregor
CMCameron Martino
Cameron Martino
CMChristian M. Metallo
Christian M. Metallo
Diabetes represents a spectrum of disease in which metabolic dysfunction damages multiple organ systems including liver, kidneys and peripheral nerves1,2. Although the onset and progression of these co-morbidities are linked with insulin resistance, hyperglycaemia and dyslipidaemia3–7, aberrant non-essential amino acid (NEAA) metabolism also contributes to the pathogenesis of diabetes8–10. Serine and glycine are closely related NEAAs whose levels are consistently reduced in patients with metabolic syndrome10–14, but the mechanistic drivers and downstream consequences of this metabotype remain unclear. Low systemic serine and glycine are also emerging as a hallmark of macular and peripheral nerve disorders, correlating with impaired visual acuity and peripheral neuropathy15,16. Here we demonstrate that aberrant serine homeostasis drives serine and glycine deficiencies in diabetic mice, which can be diagnosed with a serine tolerance test that quantifies serine uptake and disposal. Mimicking these metabolic alterations in young mice by dietary serine or glycine restriction together with high fat intake markedly accelerates the onset of small fibre neuropathy while reducing adiposity. Normalization of serine by dietary supplementation and mitigation of dyslipidaemia with myriocin both alleviate neuropathy in diabetic mice, linking serine-associated peripheral neuropathy to sphingolipid metabolism. These findings identify systemic serine deficiency and dyslipidaemia as novel risk factors for peripheral neuropathy that may be exploited therapeutically.

28 April 2020 in mSystems
Verified
Journal Article
Open access
PDF file
BTBryn C. Taylor
Bryn C. Taylor
FLFranck Lejzerowicz
Franck Lejzerowicz
MPMarion Poirel
Marion Poirel
JSJustin P. Shaffer
Justin P. Shaffer
LJLingjing Jiang
Lingjing Jiang
RKRob Knight
Rob Knight
Public interest in the effects of fermented food on the human gut microbiome is high, but limited studies have explored the association between fermented food consumption and the gut microbiome in large cohorts. Here, we used a combination of omics-based analyses to study the relationship between the microbiome and fermented food consumption in thousands of people using both cross-sectional and longitudinal data. We found that fermented food consumers have subtle differences in their gut microbiota structure, which is enriched in conjugated linoleic acid, thought to be beneficial. The results suggest that further studies of specific kinds of fermented food and their impacts on the microbiome and health will be useful.

27 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
EAErick Armingol
Erick Armingol
HBHratch M. Baghdassarian
Hratch M. Baghdassarian
CMCameron Martino
Cameron Martino
APAraceli Perez-Lopez
Araceli Perez-Lopez
CACaitlin Aamodt
Caitlin Aamodt
NLNathan Lewis
Nathan Lewis
Cell interactions determine phenotypes, and intercellular communication is shaped by cellular contexts such as disease state, organismal life stage, and tissue microenvironment. Single-cell technologies measure the molecules mediating cell–cell communication, and emerging computational tools can exploit these data to decipher intercellular communication. However, current methods either disregard cellular context or rely on simple pairwise comparisons between samples, thus limiting the ability to decipher complex cell–cell communication across multiple time points, levels of disease severity, or spatial contexts. Here we present Tensor-cell2cell, an unsupervised method using tensor decomposition, which deciphers context-driven intercellular communication by simultaneously accounting for multiple stages, states, or locations of the cells. To do so, Tensor-cell2cell uncovers context-driven patterns of communication associated with different phenotypic states and determined by unique combinations of cell types and ligand-receptor pairs. As such, Tensor-cell2cell robustly improves upon and extends the analytical capabilities of existing tools. We show Tensor-cell2cell can identify multiple modules associated with distinct communication processes (e.g., participating cell–cell and ligand-receptor pairs) linked to severities of Coronavirus Disease 2019 and to Autism Spectrum Disorder. Thus, we introduce an effective and easy-to-use strategy for understanding complex communication patterns across diverse conditions.